Continuous Manufacturing Equipment Providers

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the current state of continuous manufacturing equipment providers market and its likely evolution in the short-mid and long term.

Chapter 3 is an introductory chapter that highlights important concepts related to continuous manufacturing, including a discussion on the emergence of continuous equipment and technologies, and type of continuous manufacturing equipment presently available in the market. It further elaborates on the advantages offered by the continuous manufacturing technique, key quality / cGMP considerations, challenges associated with continuous manufacturing equipment, overview of existing regulatory guidelines and the future perspectives related to continuous manufacturing equipment.

Chapter 4 includes information on close to 380 continuous manufacturing equipment for small molecule drugs. It features a detailed analysis on type of equipment, type of manufacturing process (only continuous and batch-continuous) and stage of manufacturing (upstream process and downstream process). The chapter also features scale of operation (preclinical / clinical and commercial) and type of product (multipurpose and single purpose). Further, the chapter provides information on equipment provider(s), highlighting their year of establishment, company size, location of headquarters and key players in this domain.

Chapter 5 includes information on more than 80 continuous manufacturing equipment for biologics. It features a detailed analysis on type of equipment, type of manufacturing process (only continuous and batch-continuous) and stage of manufacturing (upstream process and downstream process). The chapter also features analysis on the scale of operation (preclinical / clinical and commercial). Further, the chapter provides information on equipment provider(s) along with information on year of establishment, company size, location of headquarters and key players in this domain.

Chapter 6 features tabulated profiles of key companies (shortlisted based on maximum number of equipment provided) providing continuous manufacturing equipment for small molecule drugs. Each profile provides an overview of the company, list of continuous manufacturing equipment, financial information (if available), and details on recent developments as well as an informed future outlook.

Chapter 7 features tabulated profiles of key companies (shortlisted based on maximum number of equipment provided) providing continuous manufacturing equipment for biologic drugs. Each profile provides an overview of the company, list of continuous manufacturing equipment, financial information (if available), and details on recent developments as well as an informed future outlook.

Chapter 8 presents an in-depth analysis of the various patents that have been filed / granted related to continuous manufacturing and affiliated equipment till 2020. It includes information on key parameters such as their publication year, geographical location, CPC symbol, emerging focus areas, type of applicant and leading industry / non-industry players (in terms of size of intellectual property portfolio). It also features a 3-D bubble analysis (based on publication year, patent citation count and extended geographical reach) and a detailed valuation analysis.

Chapter 9 features a chapter on an insightful 4-D representation, highlighting the competitiveness analysis of continuous manufacturing equipment providers for small molecules and biologics across key geographical areas, taking into consideration company experience (experience of the company), product expertise (scale of operation, type of manufacturing process, types of equipment and type of product), product portfolio (number of equipment) and company size (small, mid-sized and large companies).

Chapter 10 presents a case study on the contract manufacturing organizations having the required expertise and capabilities for continuous manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, purpose of manufacturing (in-house and contract service), scale of operation (preclinical, clinical and commercial), location of headquarter, location of continuous manufacturing facilities and type of drug molecule.

Chapter 11 presents a comprehensive market forecast analysis, highlighting the likely growth of continuous manufacturing equipment providers market, 2021 - 2030. The chapter provides likely distribution of the projected future opportunity based on type of molecule (small molecule and biologic), type of equipment (mixers, granulators, bioreactors / reactors and others), scale of operation (preclinical / clinical and commercial), stage of manufacturing (upstream and downstream process) and geography (North America, Europe and Asia Pacific).

Chapter 13 summarizes the entire report. It presents a list of key takeaways and offers an independent opinion on the current market scenario. Further, it summarizes the various evolutionary trends that are likely to influence the future of this market.

Chapter 14 is a collection of executive insights of the discussion that were held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interview held with Andrea Adamo (Founder and Chief Executive Officer, Zaiput Flow Technologies), Bayan Takizawa (Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals), Graeme Cruickshank (Chief Technology and Innovation Officer, Center for Process Innovation), Nick Thomson (Senior Director Chemical Research and Development, Pfizer) and Anonymous (Senior Manager, Continuous Manufacturing Business Development, Patheon Pharma Services).

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 14 is an appendix, which consists the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview 
3.2. Continuous Manufacturing and Affiliated Technologies
3.3. Types of Continuous Manufacturing Equipment
3.4. Advantages of Continuous Manufacturing
3.5. Quality (cGMP) Considerations
3.6. Challenges Associated with Continuous Manufacturing Equipment
3.7. Future Perspectives

4. CONTINUOUS MANUFACTURING EQUIPMENT FOR SMALL MOLECULE DRUGS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Continuous Manufacturing Equipment for Small Molecule Drugs: Overall Market Landscape
4.2.1. Analysis by Type of Equipment
4.2.2. Analysis by Type of Manufacturing Process
4.2.3. Analysis by Stage of Manufacturing
4.2.4. Analysis by Scale of Operation
4.2.5. Analysis by Type of Product

4.3. Continuous Manufacturing Equipment for Small Molecule Drugs: Developer Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Key Continuous Manufacturing Equipment Providers

5. CONTINUOUS MANUFACTURING EQUIPMENT FOR BIOLOGIC DRUGS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Continuous Manufacturing Equipment for Biologic Drugs: Overall Market Landscape
5.2.1. Analysis by Type of Equipment
5.2.2. Analysis by Type of Manufacturing Process
5.2.3. Analysis by Stage of Manufacturing
5.2.4. Analysis by Scale of Operation

5.3. Continuous Manufacturing Equipment for Biologic Drugs: Developer Landscape
5.3.1. Analysis by Year oaf Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Key Continuous Manufacturing Equipment Providers

6. CONTINUOUS MANUFACTURING EQUIPMENT FOR SMALL MOLECULE DRUGS: COMPANY PROFILES
6.1. Chapter Overview
6.2 Corning
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook

6.3. Glatt
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook

6.4. IKA
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook

6.5. Kilburn Engineering
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook

6.6. Thermo Fisher Scientific
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook

7. CONTINUOUS MANUFACTURING EQUIPMENT FOR BIOLOGIC DRUGS: COMPANY PROFILES
7.1. Chapter Overview
7.2. Eppendorf
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook

7.3. Merck Millipore
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook

7.4. Pall
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook

7.5. Sartorius
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook

7.6. TA Instruments
7.6.1. Company Overview
7.6.2. Recent Developments and Future Outlook

8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Continuous Manufacturing Technologies: Patent Analysis
8.3.1. Analysis by Publication Year
8.3.2. Analysis by Geography
8.3.3. Analysis by CPC Symbols
8.3.4. Emerging Focus Areas
8.3.5. Analysis by Type of Applicant
8.3.6. Leading Players: Analysis by Number of Patents
8.3.7. Analysis by Patent Publication Year, Patent Citation Count and Extended Family Size
8.3.8. Patent Valuation Analysis by Patent Age, Number of Citation and Geographical Reach
8.3.8.1. Leading Patents: Information by Number of Citations

9. COMPANY COMPETITIVENESS ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Key Parameters
9.3. Continuous Manufacturing Equipment Providers for Small Molecule Drugs
9.3.1. Companies based in North America
9.3.2. Companies based in Europe
9.3.3. Companies based in Asia Pacific
9.3.4. Key Players: Analysis by Company Experience, Product Expertise, Product Portfolio and Key Market Presence

9.4. Continuous Manufacturing Equipment Providers for Biologic Drugs
9.4.1. Companies based in North America
9.4.2. Companies based in Rest of the World (Europe and Asia Pacific)
9.4.3. Key Players: Analysis by Company Experience, Product Expertise, Product Portfolio and Key Market Presence

10. CASE STUDY: COMPANIES WITH EXPERTISE IN CONTINUOUS MANUFACTURING
10.1. Context and Background
10.2. Early Adopters of Continuous Manufacturing
10.3. Companies with Expertise in Continuous Manufacturing
10.3.1. Analysis by Year of Establishment
10.3.2. Analysis by Company Size
10.3.3. Analysis by Purpose of Manufacturing
10.3.4. Analysis by Scale of Operation
10.3.5. Analysis by Type of Drug Molecule
10.3.6. Analysis by Location of Headquarters
10.3.7. Analysis by Year of Establishment and Company Size (Logo Landscape)
10.3.8. Analysis by Location of Continuous Drug Manufacturing Facilities
10.4. Concluding Remarks

11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Forecast Methodology
11.3. Global Continuous Manufacturing Equipment Providers Market, 2021-2030
11.4. Continuous Manufacturing Equipment Providers Market, 2021-2030: Distribution by Type of Molecule
11.4.1. Continuous Manufacturing Equipment Providers Market for Small Molecule Drugs, 2021-2030
11.4.2. Continuous Manufacturing Equipment Providers Market for Biologics, 2021-2030

11.5. Continuous Manufacturing Equipment Providers Market, 2021-2030: Distribution by Type of Equipment
11.5.1. Continuous Manufacturing Equipment Providers Market for Mixers, 2021-2030
11.5.2. Continuous Manufacturing Equipment Providers Market for Granulators, 2021-2030
11.5.3. Continuous Manufacturing Equipment Providers Market for Dryers, 2021-2030
11.5.4. Continuous Manufacturing Equipment Providers Market for Bioreactors / Reactors, 2021-2030
11.5.5. Continuous Manufacturing Equipment Providers Market for Other Equipment, 22021-2030

11.6. Continuous Manufacturing Equipment Providers Market, 2021-2030: Distribution by Type of Manufacturing Process
11.6.1. Continuous Manufacturing Equipment Providers Market for Upstream Process, 2021-2030
11.6.2. Continuous Manufacturing Equipment Providers Market for Downstream Process, 2021-2030

11.7. Continuous Manufacturing Equipment Providers Market, 2021-2030: Distribution by Scale of Operation
11.7.1. Continuous Manufacturing Equipment Providers Market for Preclinical / Clinical Scale Operations, 2021-2030
11.7.2. Continuous Manufacturing Equipment Providers Market for Commercial Scale Operations, 2021-2030

11.8. Continuous Manufacturing Equipment Providers Market, 2021-2030: Distribution by Type of Geography
11.8.1. Continuous Manufacturing Equipment Providers Market in North America, 2021-2030
11.8.2. Continuous Manufacturing Equipment Providers Market in Europe, 2021-2030
11.8.3. Continuous Manufacturing Equipment Providers Market in Asia Pacific, 2021-2030

12. CONCLUDING REMARKS
12.1. Chapter Overview
12.2. Key Takeaway

13. INTERVIEW TRANSCRIPTS
13.1. Chapter Overview
13.2. Andrea Adamo, Founder and Chief Executive Officer, Zaiput Flow Technologies
13.3. Bayan Takizawa, Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals
13.4. Graeme Cruickshank, Chief Technology and Innovation Officer, Centre for Process Innovation
13.5. Nick Thomson, Senior Director Chemical Research and Development, Pfizer
13.6. Anonymous, Senior Manager, Continuous Manufacturing Business Development, Patheon

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Comparison between Batch and Integrated Continuous Manufacturing Processes
Figure 3.2 Types of Continuous Manufacturing Equipment
Figure 4.1 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Type of Equipment
Figure 4.2 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Type of Manufacturing Process
Figure 4.3 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Stage of Manufacturing
Figure 4.4 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Scale of Operation
Figure 4.5 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Type of Product
Figure 4.6 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Distribution by Year of Establishment
Figure 4.7 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Distribution by Company Size
Figure 4.8 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Distribution by Location of Headquarters
Figure 4.9 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Key Players
Figure 5.1 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Type of Equipment
Figure 5.2 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Type of Manufacturing Process
Figure 5.3 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Stage of Manufacturing
Figure 5.4 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Scale of Operation
Figure 5.5 Continuous Manufacturing Equipment Providers for Biologic Drugs: Distribution by Year of Establishment
Figure 5.6 Continuous Manufacturing Equipment Providers for Biologic Drugs: Distribution by Company Size
Figure 5.7 Continuous Manufacturing Equipment Providers for Biologic Drugs: Distribution by Location of Headquarters
Figure 5.8 Continuous Manufacturing Equipment Providers for Biologic Drugs: Key Players
Figure 8.1 Patent Analysis: Distribution by Type of Patent
Figure 8.2 Patent Analysis: Cumulative Year-wise Trend
Figure 8.3 Patent Analysis: Distribution by Region
Figure 8.4 Patent Analysis: Distribution by CPC Symbols
Figure 8.5 Patent Analysis: Distribution of CPC Symbols by Publication Year
Figure 8.6 Patent Analysis: Emerging Focus Areas
Figure 8.7 Patent Analysis: Distribution by Type of Applicant
Figure 8.8 Leading Industry Players: Distribution by Number of Patents
Figure 8.9 Leading Non-Industry Players: Distribution by Number of Patents
Figure 8.10 3-D Bubble Analysis: Distribution by Publication Year, Citation Count and Extended Geographical Family
Figure 8.11 Patent Analysis: Distribution by Patent Age, 2000- 2020 (till November)
Figure 8.12 Patent Analysis: Distribution by Region, Pre 2014 – 2020 (till November)
Figure 8.13 Continuous Manufacturing Technologies for Pharmaceuticals: Patent Valuation
Figure 9.1 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Small Molecules in North America
Figure 9.2 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Small Molecules in Europe
Figure 9.3 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Small Molecules in Asia Pacific
Figure 9.4 Continuous Manufacturing Equipment Providers for Small Molecules: Key Players
Figure 9.5 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Biologics in North America
Figure 9.6 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Biologics in RoW
Figure 9.7 Continuous Manufacturing Equipment Providers for Biologics: Key Players
Figure 10.1 Continuous Drug Manufacturers: Distribution by Year of Establishment
Figure 10.2 Continuous Drug Manufacturers: Distribution by Company Size
Figure 10.3 Continuous Drug Manufacturers: Distribution by Purpose of Manufacturing
Figure 10.4 Continuous Drug Manufacturers: Distribution by Scale of Operation
Figure 10.5 Continuous Drug Manufacturers: Distribution by Location of Headquarters
Figure 10.6 Continuous Drug Manufacturers: Distribution by Year of Establishment and Company Size
Figure 10.7 Continuous Drug Manufacturers: Distribution by Location of Facilities
Figure 10.8 Continuous Drug Manufacturers: Distribution by Type of Drug
Figure 12.1 Global Continuous Manufacturing Equipment Providers Market, 2021-2030
Figure 12.2 Global Continuous Manufacturing Equipment Providers Market for Small Molecules, 2021-2030
Figure 12.3 Global Continuous Manufacturing Equipment Providers Market for Biologics, 2021-2030
Figure 12.4 Continuous Manufacturing Equipment Providers Market for Mixers, 2021-2030
Figure 12.5 Continuous Manufacturing Equipment Providers Market for Granulators, 2021-2030
Figure 12.6 Continuous Manufacturing Equipment Providers Market for Dryers, 2021-2030
Figure 12.7 Continuous Manufacturing Equipment Providers Market for Bioreactors / Reactors, 2021-2030
Figure 12.8 Continuous Manufacturing Equipment Providers Market for Other Equipment, 2021-2030
Figure 12.9 Continuous Manufacturing Equipment Providers Market for Upstream Process, 2021-2030
Figure 12.10 Continuous Manufacturing Equipment Providers Marker for Downstream Process, 2021-2030
Figure 12.11 Continuous Manufacturing Equipment Providers Market for Preclinical / Clinical Operations, 2021-2030
Figure 12.12 Continuous Manufacturing Equipment Providers Market for Commercial Operations, 2021-2030
Figure 12.13 Continuous Manufacturing Equipment Providers Market in North America, 2021-2030
Figure 12.14 Continuous Manufacturing Equipment Providers Market in Europe, 2021-2030
Figure 12.15 Continuous Manufacturing Equipment Providers Market in Asia Pacific, 2021-2030

List Of Tables

Table 3.1 Batch versus Continuous Manufacturing Technology: Comparison of Key Characteristics
Table 4.1 Continuous Manufacturing Equipment for Small Molecules: Information on Type of Equipment, Type of Manufacturing Process and Stage of Manufacturing
Table 4.2 Continuous Manufacturing Equipment for Small Molecules: Information on Scale of Operation, Type of Product and Throughput / Capacity
Table 4.3 Continuous Manufacturing Equipment Providers for Small Molecules: Information of Year of Establishment, Company Size and Location of Headquarters
Table 5.1 Continuous Manufacturing Equipment for Biologics: Information on Type of Equipment, Type of Manufacturing Process and Stage of Manufacturing
Table 5.2 Continuous Manufacturing Equipment for Biologics: Information on Scale of Operation and Throughput / Capacity
Table 5.3 Continuous Manufacturing Equipment Providers for Biologics: Information of Year of Establishment, Company Size and Location of Headquarters
Table 6.1 Corning: Company Snapshot
Table 6.2 Corning: Recent Developments and Future Outlook
Table 6.3 Glatt: Company Snapshot
Table 6.4 Glatt: Recent Developments and Future Outlook
Table 6.5 IKA: Company Snapshot
Table 6.6 Kilburn Engineering: Company Snapshot
Table 6.7 Thermo Fisher Scientific: Company Snapshot
Table 6.8 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.1 Eppendorf: Company Snapshot
Table 7.2 Eppendorf: Recent Developments and Future Outlook
Table 7.3 Merck Millipore: Company Snapshot
Table 7.4 Merck Millipore: Recent Developments and Future Outlook
Table 7.5 Pall: Company Snapshot
Table 7.6 Pall: Recent Developments and Future Outlook
Table 7.7 Sartorius: Company Snapshot
Table 7.8 Sartorius: Recent Developments and Future Outlook
Table 7.9 TA Instruments: Company Snapshot
Table 7.10 TA Instruments: Recent Developments and Future Outlook
Table 8.1 Patent Analysis: Prominent CPC Symbols
Table 8.2 Patent Analysis: Most Popular CPC Symbols
Table 8.3 Patent Analysis: Top CPC Symbols
Table 8.4 Patent Valuation Analysis: Categorization based on Proprietary Scoring Criteria
Table 8.5 Patent Analysis: Distribution by Number of Citations
Table 10.1 Continuous Drug Manufacturers: Information on Year of Establishment, Company Size, Purpose of Manufacturing, Scale of Operation and Location of Headquarters
Table 10.2 Continuous Drug Manufacturers: Information on Number and Location of Production Facilities
Table 10.3 Continuous Drug Manufacturers: Information on Type of Drug Manufactured
Table 13.1 Zaiput Flow Technologies: Company Snapshot
Table 13.2 CONTINUUS Pharmaceuticals: Company Snapshot
Table 13.3 Centre for Process Innovation: Company Snapshot
Table 13.4 Pfizer: Company Snapshot
Table 13.5 Patheon: Company Snapshot
Table 14.1 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Type of Equipment
Table 14.2 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Type of Manufacturing Process
Table 14.3 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Stage of Manufacturing
Table 14.4 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Scale of Operation
Table 14.5 Continuous Manufacturing Equipment for Small Molecule Drugs: Distribution by Type of Product
Table 14.6 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Distribution by Year of Establishment
Table 14.7 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Distribution by Company Size
Table 14.8 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Distribution by Location of Headquarters
Table 14.9 Continuous Manufacturing Equipment Providers for Small Molecule Drugs: Key Players
Table 14.10 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Type of Equipment
Table 14.11 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Type of Manufacturing Process
Table 14.12 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Stage of Manufacturing
Table 14.13 Continuous Manufacturing Equipment for Biologic Drugs: Distribution by Scale of Operation
Table 14.14 Continuous Manufacturing Equipment Providers for Biologic Drugs: Distribution by Year of Establishment
Table 14.15 Continuous Manufacturing Equipment Providers for Biologic Drugs: Distribution by Company Size
Table 14.16 Continuous Manufacturing Equipment Providers for Biologic Drugs: Distribution by Location of Headquarters
Table 14.17 Continuous Manufacturing Equipment Providers for Biologic Drugs: Key Players
Table 14.18 Patent Analysis: Distribution by Type of Patent
Table 14.19 Patent Analysis: Cumulative Year-wise Trend
Table 14.20 Patent Analysis: Distribution by Geographical Region
Table 14.21 Patent Analysis: Distribution by CPC Symbols
Table 14.22 Patent Analysis: Distribution of CPC Symbols by Publication Year
Table 14.23 Patent Analysis: Emerging Focus Areas
Table 14.24 Patent Analysis: Distribution by Type of Applicant
Table 14.25 Leading Industry Players: Distribution by Number of Patents
Table 14.26 Leading Non-Industry Players: Distribution by Number of Patents
Table 14.27 3-D Bubble Analysis: Distribution by Publication Year, Citation Count and Extended Geographical Family
Table 14.28 Patent Analysis: Distribution by Patent Age, 2000- 2020 (till November)
Table 14.29 Patent Analysis: Distribution by Region, Pre 2014 – 2020 (till November)
Table 14.30 Continuous Manufacturing Technologies for Pharmaceuticals: Patent Valuation
Table 14.31 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Small Molecules in North America
Table 14.32 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Small Molecules in Europe
Table 14.33 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Small Molecules in Asia Pacific
Table 14.34 Continuous Manufacturing Equipment Providers for Small Molecules: Key Players
Table 14.35 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Biologics in North America
Table 14.36 Company Competitiveness Analysis: Continuous Manufacturing Equipment Providers for Biologics in RoW
Table 14.37 Continuous Manufacturing Equipment Providers for Biologics: Key Players
Table 14.38 Continuous Drug Manufacturers: Distribution by Year of Establishment
Table 14.39 Continuous Drug Manufacturers: Distribution by Company Size
Table 14.40 Continuous Drug Manufacturers: Distribution by Purpose of Manufacturing
Table 14.41 Continuous Drug Manufacturers: Distribution by Scale of Operation
Table 14.42 Continuous Drug Manufacturers: Distribution by Location of Headquarters
Table 14.43 Continuous Drug Manufacturers: Distribution by Year of Establishment and Company Size
Table 14.44 Continuous Drug Manufacturers: Distribution by Location of Facilities
Table 14.45 Continuous Drug Manufacturers: Distribution by Type of Drug
Table 14.46 Global Continuous Manufacturing Equipment Providers Market, 2021-2030
Table 14.47 Global Continuous Manufacturing Equipment Providers Market for Small Molecules, 2021-2030
Table 14.48 Global Continuous Manufacturing Equipment Providers Market for Biologics, 2021-2030
Table 14.49 Continuous Manufacturing Equipment Providers Market for Mixers, 2021-2030
Table 14.50 Continuous Manufacturing Equipment Providers Market for Granulators, 2021-2030
Table 14.51 Continuous Manufacturing Equipment Providers Market for Dryers, 2021-2030
Table 14.51 Continuous Manufacturing Equipment Providers Market for Bioreactors / Reactors, 2021-2030
Table 14.52 Continuous Manufacturing Equipment Providers Market for Other Equipment, 2021-2030
Table 14.53 Continuous Manufacturing Equipment Providers Market for Upstream Process, 2021-2030
Table 14.54 Continuous Manufacturing Equipment Providers Marker for Downstream Process, 2021-2030
Table 14.55 Continuous Manufacturing Equipment Providers Market for Preclinical / Clinical Operations, 2021-2030
Table 14.56 Continuous Manufacturing Equipment Providers Market for Commercial Operations, 2021-2030
Table 14.57 Continuous Manufacturing Equipment Providers Market in North America, 2021-2030
Table 14.58 Continuous Manufacturing Equipment Providers Market in Europe, 2021-2030
Table 14.59 Continuous Manufacturing Equipment Providers Market in Asia Pacific, 2021-2030

List Of Companies

The following companies and organizations have been included in the report.

1. 3D Biotek
2. AbbVie
3. Ajax Equipment
4. Alexanderwerk
5. Allgaier Process Technology
6. Amgen
7. amixon
8. Applikon Biotechnology
9. AstraZeneca
10. AWL (Alconbury Weston Limited)
11. Baker Perkins
12. bbi-biotech
13. Boeing
14. Cell Culture Company
15. Cellec Biotek 
16. Centre for Process Innovation
17. Changzhou Ruide Drying Engineering Technology
18. Chemtrix
19. Commonwealth Scientific and Industrial Research Organization
20. CONTINUUS Pharmaceuticals
21. Coperion
22. Corning
23. Cytiva
24. DCI-Biolafitte
25. Design Integrated Technology
26. DEVEX Verfahrenstechnik
27. DRIAM 
28. Eli Lilly
29. Eppendorf
30. Evaporators & Dryers Engineering 
31. Florida State University
32. Freund
33. GEA
34. Gericke
35. Gilead Sciences
36. Glatt
37. Hosokawa Micron Powder Systems
38. Hovione
39. IKA
40. Iowa Mixing and Process Equipment Company
41. Janssen
42. Jaygo 
43. Kemutec 
44. Kevin Process Technologies
45. Kilburn Engineering
46. KORSCH
47. Kurimoto
48. L.B. Bohle
49. LCI
50. Lödige Process Technology
51. Massachusetts Institute of Technology
52. Merck
53. Metso
54. Munson Machinery
55. Neuhaus Neotec
56. NiTech Solutions
57. Novartis
58. E.T. Oakes
59. O'Hara Technologies
60. OmniBRx Biotechnologies
61. Pall Life Sciences
62. Patheon
63. Pfizer
64. Pierre Guerin
65. Proton Engineers
66. Purdue University
67. Puschner
68. Readco Kurimoto
69. Repligen
70. Riera Nadeu
71. Shuanglong Group
72. S. Howes
73. SaintyCo
74. Saka Engineering Systems
75. Sartorius
76. Scott Equipment Company
77. Semba Biosciences
78. Senieer
79. Shachi Engineering 
80. Shree Bhagwati Machtech
81. Buss-SMS-Canzler
82. Sonic 
83. SPX FLOW
84. Stalam
85. STEERLife
86. Sturtevant
87. symex
88. Syntegon
89. Synthecon
90. TA Instruments
91. Tema Process
92. The Young Industries
93. Thermo Fisher Scientific
94. Thomas
95. Uni-Mech Industries
96. University of California
97. University of Illinois
98. Vapourtec
99. Vertex
100. XPure
101. Yenchen Machinery 
102. YMC Process Technologies
103. Zaiput Flow Technologies